These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8792767)

  • 21. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
    Derechin VM; Blinder MA; Tollefsen DM
    J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of glycosaminoglycans with heparin cofactor II.
    Tollefsen DM
    Ann N Y Acad Sci; 1994 Apr; 714():21-31. PubMed ID: 8017769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of heparin cofactor II by calcium spirulan.
    Hayakawa Y; Hayashi T; Lee JB; Ozawa T; Sakuragawa N
    J Biol Chem; 2000 Apr; 275(15):11379-82. PubMed ID: 10753952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition.
    Mitchell JW; Church FC
    J Biol Chem; 2002 May; 277(22):19823-30. PubMed ID: 11856753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
    Maimone MM; Tollefsen DM
    J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
    Tollefsen DM
    Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin.
    Williams SP; Mason RM
    Arch Biochem Biophys; 1991 Jun; 287(2):386-96. PubMed ID: 1716868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition.
    Ciaccia AV; Monroe DM; Church FC
    J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate.
    Blinder MA; Andersson TR; Abildgaard U; Tollefsen DM
    J Biol Chem; 1989 Mar; 264(9):5128-33. PubMed ID: 2647747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
    Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
    J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM; Whinna HC; Gentry HR; Myles T; Leung LL; Church FC
    J Biol Chem; 2004 Oct; 279(41):43237-44. PubMed ID: 15292227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
    Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
    Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.
    Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M
    Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
    Kinsella MG; Irvin C; Reidy MA; Wight TN
    Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.